Phase II trial of bevacizumab and irinotecan in the treatment of malignant gliomas

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Goli, KJ; Desjardins, A; Herndon, JE; Rich, JN; Reardon, DA; Quinn, JA; Sathornsumetee, S; Bota, DA; Friedman, HS; Vredenburgh, JJ

Published Date

  • June 20, 2007

Published In

Volume / Issue

  • 25 / 18

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X